Operator Greetings, and welcome to the INmune Bio fourth-quarter 2020 earnings conference call. [Operator instructions] As a reminder, this conference call is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr. David Moss, co-founder and CFO of INmune Bio. David, the floor is yours. David Moss -- Co-Founder and Chief Executive Officer Thank you, Rob, and good afternoon, everybody. We thank you for joining us for the call for INmune Bio's fourth-quarter 2020 financial results. With me on the call is Dr. RJ Tesi, CEO and co-founder of INmune Bio, who will provide a business update.